Workflow
ST凯利: 关于公司股票被实施其他风险警示相关事项的进展公告

Core Viewpoint - Shanghai Kelly Medical Technology Co., Ltd. is facing risk warnings due to an audit report from Zhonghua Accounting Firm indicating an inability to express an opinion on the company's internal controls for the 2024 financial year [1][2]. Group 1: Risk Warnings - The company’s stock trading has been subjected to other risk warnings as per the Shenzhen Stock Exchange's rules due to the audit report [1]. - The company is at risk of being subject to delisting warnings if the internal control audit report remains unaddressed [1]. Group 2: Measures Taken - The board of directors is taking the audit report seriously and has implemented measures to mitigate the issues raised [2]. - The company has revised its authority and established stricter review standards, along with conducting specialized training on related party transactions [2]. - The company is focusing on key investment projects, monitoring industry conditions, cash flow, debt structure, and compliance to avoid investment risks [2]. Group 3: Compliance and Reporting - The company encourages employees and stakeholders to report any internal violations or fraud to reduce the chances of misconduct [3]. - During the warning period, the company is required to disclose progress updates at least once a month until the situation is resolved [3].